Fulminant diabetes mellitus and concomitant enterovirus infection: a clinical case

T. V. Saprina; N. N. Musina; S. V. Vtorushin; N. V. Krakhmal’; Yu. V. Rogovskaya

doi:10.18821/0869-2106-2020-26-2-125-132

Russian Medicine ›› 2020, Vol. 26 ›› Issue (2) : 125 -132. DOI: 10.18821/0869-2106-2020-26-2-125-132

Case reports

review-article

Fulminant diabetes mellitus and concomitant enterovirus infection: a clinical case

Author information +

History +

PDF

Abstract

Fulminant type 1 diabetes mellitus is a subtype of diabetes mellitus. It is characterized by the extremely rapid development of hyperglycemia and ketoacidosis because of the near-total destruction of pancreatic β-cells. A clinical case of lethal, type 1, fulminant diabetes mellitus is presented. The patient management strategy and possible causes of the adverse course and outcome of the disease are analyzed.

Keywords

clinical case / fulminant diabetes mellitus / type 1 diabetes mellitus / ketoacidosis / infectious myocarditis / insulin

Cite this article

Download citation ▾

T. V. Saprina, N. N. Musina, S. V. Vtorushin, N. V. Krakhmal’, Yu. V. Rogovskaya. Fulminant diabetes mellitus and concomitant enterovirus infection: a clinical case. Russian Medicine, 2020, 26(2): 125-132 DOI:10.18821/0869-2106-2020-26-2-125-132

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Imagawa A., Hanafusa T., Miyagawa J., Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N. Engl. J. Med. 2000; 342(5): 301–7. Doi: 10.1056/NEJM200002033420501.

[2]	Moreau C., Drui D., Arnault-Ouary G., Charbonnel B., Chaillous L., Cariou B. Fulminant type 1 diabetes in Caucasians: a report of three cases. Diabetes Metab. 2008; 34(5): 529–32. Doi: 10.1016/j.diabet.2008.05.003.

[3]	Imagawa A., Hanafusa T., Uchigata Y., Kanatsuka A., Kawasaki E., Kobayashi T. et al. Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care. 2003; 26(8): 2345–52. Doi: 10.2337/diacare.26.8.2345.

[4]	Imagawa A., Hanafusa T. Pathogenesis of fulminant type 1 diabetes. Rev Diabet Stud. 2006; 3(4): 169–77. Doi: 10.1900/RDS.2006.3.169.

[5]	Imagawa A., Hanafusa T., Makino H., Miyagawa J.I., Juto P. High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes. Diabetologia. 2005 Feb; 48(2): 290–3. Doi: 10.1007/s00125-004-1624-z.

[6]	Tanaka S., Nishida Y., Aida K., Maruyama T., Shimada A., Suzuki M. et al. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes. Diabetes. 2009; 58(10): 2285–91. Doi: 10.2337/db09-0091.

[7]

Imagawa A., Hanafusa T., Awata T., Ikegami H., Uchigata Y., Osawa H. et al. Report of the Committee of the Japan Diabetes Society on the research of fulminant and acute-onset type 1 diabetes mellitus: new diagnostic criteria of fulminant type 1 diabetes mellitus (2012). Diabetes Investig. 2012; 3(6): 536–9. Doi: 10.1111/jdi.12024.

[8]	Uto T., Uto K., Teno S., Isono K., Omori Y. A case of fulminant type 1 diabetes mellitus detected after cardiac arrest due to diabetic ketoacidosis. J Japan Diab Soc. 2002; 45(9): 689–93. Doi: 10.11213/tonyobyo1958.45.689.

[9]	Shimizu I., Makino H., Imagawa A., Iwahashi H., Uchigata Y., Kanatsuka A., Clinical and Immunogenetic Characteristics of Fulminant Type 1 Diabetes Associated With Pregnancy. J Clin Endocrinol Metab. 2006; 91(2): 471-6. Doi: 10.1210/jc.2005-1943.